21 Novembre 2026

Psicologia Punto One | Psicologia e Psicologi nel Web

Menu

Menu

SCHEDA SCIENTIFICA2026Altra ricerca

Primary health care nursing interventions for people who use drugs: a scoping review.

Acuña-Forero LM, Sosa-Rodríguez YL, Cárdenas-Martínez FJ, Sánchez-Rodríguez JM

Revista Cuidarte · 2026

Abstract originale

INTRODUCTION: Drug use is a public health concern due to its high prevalence and associated biopsychosocial consequences. Despite theimportanceofharmreductioninprimaryhealthcare, aknowledge gap exists regarding the specific interventions implemented by nurses. OBJECTIVE: To describe the nursing interventions that can be implemented within primary health care for people who use drugs to reduce harm associated with drug use. MATERIALS AND METHODS: A scoping review was conducted following the Arksey and O'Malley framework. The literature search was conducted in PubMed, VHL, ProQuest, and Google Scholar in July 2024. RESULTS: A total of 1,518 studies were identified; of which 12 met the eligibility criteria for analysis: 10 retrieved from databases and 2 from Google Scholar. Five categories emerged from the analysis, of which educational/ psychoeducational interventions were the most frequently reported (75%), followed by preventive and risk-mitigation practices (50%) and clinical and emotional support interventions (42%). DISCUSSION: The role of nursing in reducing harm from drug use is highlighted, given that interventions ranging from education and psychological support through cognitive-behavioral therapy to preventive actions and clinical risk mitigation practices contribute to the well-being and care of each person. CONCLUSION: Nursing interventions in primary health care are key to improving quality of life and require specific training for professionals and policies that facilitate access to harm reduction resources.

Parole chiave

Harm ReductionNursingPrimary Health CarePsychotropic Drugs
Leggi il testo integrale originale

Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.

Primary health care nursing interventions for people who use drugs: a scoping review Intervenciones de enfermería en atención primaria dirigidas a personas consumidoras de drogas: revisión de alcanceIntervenções de enfermagem na atenção primária para usuários de drogas: uma revisão de escopo

Abstract:

Introduction:

Drug use is a public health concern due to its high prevalence and associated biopsychosocial consequences. Despite theimportanceofharmreductioninprimaryhealthcare, aknowledge gap exists regarding the specific interventions implemented by nurses.

Objective:

To describe the nursing interventions that can be implemented within primary health care for people who use drugs to reduce harm associated with drug use.

Materials and Methods:

A scoping review was conducted following the Arksey and O’Malley framework. The literature search was conducted in PubMed, VHL, ProQuest, and Google Scholar in July 2024.

Results:

A total of 1,518 studies were identified; of which 12 met the eligibility criteria for analysis: 10 retrieved from databases and 2 from Google Scholar. Five categories emerged from the analysis, of which educational/ psychoeducational interventions were the most frequently reported (75%), followed by preventive and risk-mitigation practices (50%) and clinical and emotional support interventions (42%).

Discussion:

The role of nursing in reducing harm from drug use is highlighted, given that interventions ranging from education and psychological support through cognitive-behavioral therapy to preventive actions and clinical risk mitigation practices contribute to the well-being and care of each person.

Conclusion:

Nursing interventions in primary health care are key to improving quality of life and require specific training for professionals and policies that facilitate access to harm reduction resources.

Introduction

Drug use is a phenomenon of growing concern worldwide. According to the Global Drug Report 2023, approximately 296 million users were recorded in 2021, representing a 23% increase over the past decade. Among the most commonly used drugs, cannabis tops the list with 219 million users, followed by amphetamines (36 million) and cocaine (22 million) worldwide1.

In Latin America and the Caribbean, at least 4.4 million men and 1.2 million women have experienced drug-related disorders at some point in their lives2,3. In Colombia, alcohol and tobacco remain the most prevalent substances, with consumption rates of 88.84% and 50.39%, respectively. However, there has been an increase in the use of opioids without a prescription, rising from 1.38% in 2016 to 3.94% in 20222,3.

The impact of drug use extends beyond the individual, affecting public health, safety, and social cohesion. Psychological, social, and environmental factors influence the onset and continuation of drug use, highlighting the need to address this issue through a comprehensive approach4, given that health consequences range from cardiovascular diseases, neuropsychological disorders, and cognitive decline to an increased risk of communicable infections such as human immunodeficiency virus (HIV) and hepatitis C5,6.

Despite the increased demand for care for people with problematic drug use, training for health personnel, especially in the nursing field, remains limited, which hinders the implementation of effective prevention and harm reduction strategies7.

Furthermore, harm reduction has proven to be a strategy based on systematic, evidence-based interventions to minimize the consequences associated with drug use by promoting access to health services, reducing morbidity and mortality, and mitigating the social impact of this problem8. Programs such as naloxone distribution9,10, supervised consumption sites, and substitution treatments have shown positive results in reducing overdoses and preventing diseases11,12.

In Colombia and Latin America, drug use is on the rise, and coverage of these programs remains insufficient, highlighting the need to strengthen public policies and the training of health personnel for the implementation of strategies and interventions in this area13,14.

In this context, nursing plays a crucial role in the care of people with problematic drug use. Within Primary Health Care (PHC), nursing professionals can play a key role in the prevention, early detection, and timely follow-up of these cases15,16. Training in harm reduction strategies not only improves the quality of care but also contributes to destigmatization and equitable access to health services17,18. Additionally, there is a lack of consistency in the literature on specific interventions for this discipline in this context; therefore, a scoping review would allow for mapping and synthesizing available knowledge, and identifying research gaps. This aims to achieve a better approach to health from a more humanistic and inclusive perspective within health systems.

Therefore, the objective of this review is to describe nursing interventions that can be implemented within primary health care (PHC) for people who use drugs to reduce harm associated with drug use, as reported in the scientific literature.

Materials and Methods

This article is a scoping review, which was conducted following the methodological framework proposed by Arksey and O’Malley and adapted by Levac, Colquhoun, and O’Brien19.

Identification of the Research Question

Initially, the research question “What interventions do primary health care nursing professionals implement to reduce harm associated with drug use?” was identified using the PIO framework.

Identification of Relevant Studies

To identify the studies, a search was conducted in the following databases—PubMed/Medline, the Virtual Health Library (VHL), and ProQuest—in July 2024, using a specific search strategy. The search strategy was carried out using Boolean operators (AND, OR, NOT) and Medical Subject Headings (MeSH) and Descriptores en Ciencias de la Salud (DeCS) terms available in the Virtual Health Library (VHL). As an additional source, a sensitive search strategy was conducted in Google Scholar using the terms: ("Drug Users" + "primary care nursing" + "harm reduction"). The search strategies used in each database are presented in Table 1.

Table 1 Final search strategy specific to each database

PUBMED

(((((((((Substance Abuse, Oral[Title/Abstract]) OR (Substance Abuse, Oral[MeSH Terms])) OR (Drug Users[Title/Abstract])) OR (Drug Users[MeSH Terms])) OR (Substance-Related Disorders[Title/Abstract])) OR (Substance-Related Disorders[MeSH Terms])) OR (Psy-chotropic Drugs[Title/Abstract])) OR (Psychotropic Drugs[MeSH Terms])) AND ((((((((((Nursing[Title/Abstract]) OR (Nursing[MeSH Terms])) OR (Nursing Care[Title/Abstract])) OR (Nursing Care[MeSH Terms])) OR (Nurses[Title/Abstract])) OR (Nurses[MeSH Ter-ms])) OR (primary care nursing[Title/Abstract])) OR (primary care nursing[MeSH Terms])) OR (Primary Nursing[Title/Abstract])) OR (Primary Nursing[MeSH Terms]))) AND ((((((((((harm reduction[Title/Abstract]) OR (harm reduction[MeSH Terms])) OR (Risk Re-duction Behavior[Title/Abstract])) OR (Risk Reduction Behavior[MeSH Terms])) OR (Disaster Management[Title/Abstract])) OR (Di-saster Management[MeSH Terms])) OR (Risk Management[Title/Abstract])) OR (Risk Management[MeSH Terms])) OR (Risk Evalua-tion Mitigation[Title/Abstract])) OR (Risk Evaluation and Mitigation[MeSH Terms]))

Virtual Health Library

((nursing) OR (mh:(nursing)) OR (nursing care) OR (mh:(nursing care)) OR (nurses) OR (mh:(nurses)) OR (primary care nursing) OR (mh:(primary care nursing)) OR (primary nursing) OR (mh:(primary nursing))) AND ((substance abuse, oral) OR (mh:(substance abuse, oral)) OR (substance abuse, oral) OR (mh:(substance abuse, oral)) OR (drug users) OR (mh:(drug users)) OR (substance-related disorders) OR (mh:(substance-related disorders)) OR (psychotropic drugs) OR (mh:(psychotropic drugs))) AND ((harm reduction) OR (mh:(harm reduction)) OR (risk reduction behavior) OR (mh:(risk reduction behavior)) OR (disaster management) OR (mh:(disaster management)) OR (risk management) OR (mh:(risk management)) OR (risk evaluation AND mitigation) OR (mh:(risk evaluation AND mitigation)))

ProQuest

(noft(Substance Abuse, Oral) OR subject(Substance Abuse, Oral) OR noft(drug users) OR subject(Drug Users) OR noft(Substance-Re-lated Disorders) OR subject(Substance-Related Disorders) OR noft(Psychotropic Drugs) OR subject(Psychotropic Drugs)) AND (noft(-Nursing) OR subject(Nursing) OR noft(Nursing Care) OR subject(Nursing Care) OR noft(Nurses) OR subject(Nurses) OR noft(primary care nursing) OR subject(primary care nursing) OR noft(Primary Nursing) OR subject(Primary Nursing)) AND (noft(harm reduction) OR subject(harm reduction) OR noft(Risk Reduction Behavior) OR subject(Risk Reduction Behavior) OR noft(Disaster Management) OR subject(Disaster Management) OR noft(Risk Management) OR subject(Risk Management) OR noft(risk evaluation AND mitigation) OR subject(risk evaluation AND mitigation))

Study Selection

During the literature review, the following inclusion criteria were considered: articles involving nursing interventions; articles involving people who use drugs as the target population; articles addressing primary health care (PHC); articles focused on harm reduction; articles published in Spanish, English, Portuguese, and French; and articles with full-text availability. The exclusion criteria were theoretical review articles, opinion pieces, commentaries, editorials, letters, conference abstracts, case reports or case series, and articles in which the study population had an additional condition besides drug use (e.g., chronic noncommunicable diseases, cardiovascular diseases, depression, among others).

Furthermore, no time restrictions were applied to the database searches to avoid publication and information bias.

Subsequently, the search results were exported from each database, and study selection was performed using the Rayyan QCRI20. In the first stage, duplicate records were removed independently by two reviewers. Next, each article underwent title and abstract screening to identify discrepancies in the inclusion and exclusion criteria, which served as the basis for information screening. These discrepancies were resolved jointly by consensus between the two reviewers. The full-texts of the selected articles were then retrieved for subsequent verification and analysis. The selection process was reported using the PRISMA flowchart.

Data Charting

To extract data from each study, a Microsoft Excel® data charting was developed to collect and organize the data, with the aim of extracting the following variables: title, author, year of publication, country where the study was conducted, study design, study objective, population, and type of intervention.

Collating, summarizing, and reporting the results

For reporting the results, the PRISMA Extension for Scoping Reviews (PRISMA-ScR) recommendations were followed21. First, the study selection phase is presented, followed by the individual characteristics of the included articles through a summary figure. Some articles were found to share the risk reduction approach, leading to the creation of 5 categories to group the interventions; however, each intervention was also analyzed individually. The information extracted from the studies and supplementary material is available on the Figshare platform22.

Ethical Considerations

This study is classified as research without ethical risk, since all sources used have been properly cited in accordance with the principles of academic rigor and the ethical principles set forth in Resolution 8430 of 199323. Therefore, it did not require approval from the Ethics Committee, in accordance with local regulations.

Results

Identification of Studies

A total of 1,518 articles were initially identified. After duplicate removal and title and abstract screening, 57 articles remained for full-text review, of which 47 were excluded, leaving 10 studies for analysis. In addition, 77 studies were identified in other sources (Google Scholar), of which only 2 met the established criteria, resulting in a total of 12 articles included in the review24–35. Details are presented in Figure 1.

Study characteristics

The identified studies were conducted primarily in the United States, in states such as New Jersey and California (6), and to a lesser extent from Asia (1), South Africa (1), Toronto/Canada (1), Australia (1), Spain (1), and Cuernavaca/Mexico (1). The publications spanned the period from 2001 to 2022 and employed various methodological approaches: quantitative (8/12), mixed-methods (3/12), and qualitative (1/12).

Individual characteristics of the studies

The individual characteristics of the articles highlight the importance of the role of nursing professionals in the care of drug-using patients in clinical settings, educational settings, and supervised consumption sites; these results are shown in Table 2.

Characteristics of interventions for people who use drugs

In the field of healthcare, strategies for managing drug use and harm reduction are essential to mitigate its negative effects. Through clinical and community-based interventions, healthcare professionals implement various actions aimed at preventing overdoses, reducing the transmission of infectious diseases, offering timely treatments, and providing comprehensive support to people with addiction problems.

Therefore, based on the interventions identified in the reviewed articles, five main categories were defined, which are summarized in Figure 2 and described in detail in Supplementary Material 1 .

Table 2Individual characteristics of the studies

Author/year/ country Study objective Study design Population Type of intervention

Cataldo31 2001 USA To highlight the importance of the role of psychiatric nurses in the assessment and treatment of tobacco use. Quantitative descriptive Psychiatric patients and individuals with substance use disorders • Pharmacological treatment to quit smoking.

• Individualized counseling to quit smoking.

• Education on the risks and benefits of quitting smoking.

• Ongoing follow-up and emotional support for patients.

WHO25 2008 Asia Describe the management of health problems in drug users Descriptive Healthcare professionals • Medical treatment for infections and diseases common among drug users. Vaccination against hepatitis and tetanus.

• Provision of clean needles and sterile injection equipment.

• Education on the prevention of infectious diseases.

Pengpid et al.26, 2013 South Africa To evaluate the effectiveness of a Screening and Brief Intervention- SBI for alcohol problems among university students in South Africa. Quantitative study - controlled trial College students • Screening to identify problematic alcohol use.

• Brief intervention to discuss strategies for reducing excessive alcohol consumption.

• Information-Motivation-Behavioral Skills (IMB) model.

Burr et al.30, 2014 USA / New Jersey To describe the implementation of a nurse-led health promotion and disease prevention program in needle exchange programs. Quantitative Descriptive People who inject drugs • Provision of clean syringes and safe injection equipment.

• Access to medical care and HIV/hepatitis testing.

• Education on safe injection practices and overdose prevention.

Patestos et al.27, 2014 USA Analyzes the roles of school nurses in preventing substance abuse among school-aged children through a model of continuous care. Quantitative descriptive School-aged children and adolescents • Early detection of substance abuse problems.

• Educational programs in schools on the risks of drug use.

• Connecting students with counseling or treatment services.

Gutierrez et al.24, 2015 USA To identify the current prevalence and societal impact, as well as the etiology, comorbid psychiatric disorders, and treatment and prevention of drug and alcohol use among adolescents. Descriptive study Adolescents • Education on the harmful effects of alcohol and drug use.

• Behavioral and family therapies.

• Prevention of initiation of use through informational talks.

Sharma et al.32, 2017 Toronto Canada Involving people with firsthand experience with drug use as partners in the delivery of clinical care. Quantitative study Adults and adolescents • Provision of sterile supplies (syringes) to drug users.

• Treatment of drug-related infections.

Lintzeris et al.28, 2020 Australia Implement and evaluate a NHT intervention targeting individuals at high risk of opioid overdose, specifically those with a history of opioid use disorder and/or injection drug use. Mixed-methods study Adults and adolescents • Distribution of naloxone and training on its use.

• Education on how to identify signs of overdose.

Mullennix et al.34, 2020 USA Describe the implementation of a clinical nurse specialist-led emergency department overdose education and naloxone distribution program. Quantitative study Patients of all ages who have experienced an opioid overdose or are at risk of opioid overdose • Naloxone distribution in the emergency department.

• Training for patients and family members on naloxone administration.

• Screening of patients at risk of opioid overdose.

• Education on the risks of overdose and opioid use.

• Referral to opioid dependence treatment services.

• Post-discharge follow-up to ensure access to care and treatment resources.

Clua-García35, 2021 Spain Understanding nursing care in supervised consumption sites (SCSs) and proposals for more effective intervention. Qualitative study with an ethnographic approach People in vulnerable situations • Supervision and care in supervised consumption sites.

• Connection to health services and treatment for drug users.

Perera et al.33, 2022 California To describe the implementation of a hospital-based intervention that provides harm reduction education and supplies to patients through an addiction consultation team at an urban safety-net hospital. Quantitative study Adults • Implementation of harm reduction programs in hospitals.

• Provision of medical care to people with substance use disorder.

Morales Loyola29, 2020- 2022 Cuernavaca Promoting social skills through an e-Health educational initiative with a focus on reducing the risks and harms of psychoactive substance use among school-aged adolescents in the State of Mexico. Nonexperimental study with prepost intervention measurement using a mixedmethods approach Secondary school adolescents • Use of digital platforms for education on the risks of substance use.

• Prevention of problematic use among adolescents through accessible information.

• Education on the risks of substance use through the use of digital platforms.

HIV: Human Immunodeficiency Virus, NHT: Take-home naloxone, SCSs: Supervised consumption sites

Educational or psychoeducational interventions

The results show that educational interventions led by nursing professionals were the most frequently reported in the included studies. These strategies were primarily aimed at strengthening knowledge about the risks associated with substance use, promoting self-care practices, and harm reduction24.

Through educational programs in various settings, they aimed to raise awareness of the risks of tobacco, alcohol, and other drug use using the 5R model (relevance, risks, rewards, roadblocks, and repetition), seeking to increase patients’ motivation to quit25,26.

In schools, these interventions provided students with a comprehensive understanding of the harmful effects of drugs, leading to a decrease in their use. Additionally, brief interventions were conducted with students at risk of substance use, informing them about the physical, psychological, and social effects of substance use and strengthening their willingness to adopt healthier behaviors27.

Other strategies included education on safe injection practices and overdose prevention, training to recognize signs of overdose and the proper use of naloxone, which helped connect users with community treatment and mental health services, strengthening comprehensive care and promoting safer practices25,30.

Clinical Interventions

It was observed that clinical interventions provided by nursing professionals, such as smoking cessation treatment through counseling and pharmacological therapies, proved effective in reducing physical and psychological dependence, increasing motivation to quit using31. Likewise, interventions aimed at treating infections and communicable diseases in people who use drugs were described, including sexually transmitted infections, skin lesions, and abscesses associated with injection drug use, through the use of antibiotics, antivirals, and procedures such as incision and drainage, when necessary, along with vaccination programs against Hepatitis B and tetanus.

Furthermore, the integration of medical services—such as testing for infectious diseases, treatments, and management of chronic conditions—significantly improved access to healthcare, promoting improvements in the overall health of the drug-using population and increasing their adherence to treatments30. This strategy emerged as a key factor in improving quality of life and reducing barriers to accessing health services33.

Emotional and Motivational Support Interventions

These were aimed at strengthening treatment adherence and promoting behavioral changes related to substance use. Early identification of at-risk students facilitated access to support networks within the school setting, making nursing professionals a key entry point for those seeking assistance27.

One of the main strategies was the Information-Motivation-Behavioral Skills (IMB) model, which combines information provision with strategies to strengthen motivation and develop behavioral skills that reduce risky behaviors.

Nursing professionals played an essential role in guiding and referring patients to health services, treatment programs, and social resources, promoting a holistic approach that integrates harm reduction and comprehensive medical care30, based on the 5A model (ask, advise, assess, assist, and arrange follow-up). They also involved families in the intervention process, strengthening the support network and creating a more favorable environment for recovery24.

Preventive Interventions

The studies focused on the early detection of substance use and the reduction of risk factors, especially among adolescents and students. Through screening programs and risk identification questionnaires, nursing staff have been able to intervene promptly, preventing problematic patterns from evolving into more serious disorders26,27. Their work in school settings through educational programs and informational talks, in collaboration with students, parents, and teachers, has been key to promoting healthy lifestyles, strengthening resilience to social pressure, and preventing the onset or continuation of drug use24. In addition, the use of digital platforms has been promoted to facilitate informed decision-making and to reinforce general health promotion, including the prevention of communicable diseases and opioid overdoses29.

Practical interventions for risk mitigation

Harm reduction interventions in the care of people who use drugs, both in hospital and community settings, are essential strategies aimed at minimizing the risks associated with drug use without requiring abstinence. Among the most notable initiatives are sterile syringe exchange programs, which have successfully reduced the transmission of infections such as HIV and hepatitis C, and the distribution of naloxone kits, empowering users and communities to respond to overdoses and effectively save lives25,32.

Other relevant strategies include supervised consumption sites, where health professionals supervise substance use under safe conditions, and the provision of safe injection kits in hospitals34,35. These measures not only reduce immediate risks such as overdose and infections but also facilitate access to health services and rehabilitation programs.

Discussion

The results of this study show that nursing interventions aimed at harm reduction for people who use drugs, developed within the PHC setting, focus on protecting life by strengthening access to health services, as well as on reducing the transmission of HIV and hepatitis B and mortality from overdose. Furthermore, these interventions help protect the dignity of people who use drugs by promoting respect for autonomy and non-stigmatization.

PHC represents individuals’ first point of contact with the healthcare system and enables the creation of ongoing therapeutic relationships with patients24,26. Barbara Starfield emphasizes that PHC is characterized by providing person-centered, continuous, and coordinated care across different health services—essential elements for adequately addressing the needs of vulnerable groups36.

From this perspective, the nursing team plays a fundamental role in implementing strategies such as early detection of substance use, health education, brief counseling, and ongoing follow-up with individuals who use drugs. Martínez Esquivel further emphasizes that nursing professionals who provide substance use counseling must cultivate skills such as active listening, empathy, and assertive communication. These qualities foster a therapeutic relationship based on respect and trust toward the user16.

These skills facilitate treatment through an approach that is not stigmatizing but rather understanding, which makes it easier to provide guidance on the risks associated with drug use and to promote safer practices14,15. In general, these proposals support the essential role of nursing in implementing PHC-based interventions that help reduce the risks and adverse effects associated with drug use, and improve access to health services and the individual’s well-being15,16.

Among the interventions identified in the literature, health education stands out as one of the most frequently implemented strategies in nursing care for people who use drugs. These actions include providing information on the risks associated with drug use, early identification of signs of overdose, promotion of safer drug use practices, and guidance on timely access to health services. Together, these interventions contribute to increasing individuals’ knowledge, strengthening their capacity for informed decision-making, and reducing the adoption of risky behaviors, which promotes health protection and the prevention of adverse events associated with drug use26.

Complementarily, the literature describes specific clinical interventions aimed at preventing overdose deaths, among which the distribution of naloxone accompanied by training in its use stands out. This strategy is primarily implemented in contexts where opioid use constitutes a significant public health problem. Evidence shows that take-home naloxone programs are an effective measure for reducing mortality by enabling an immediate response to potentially fatal events. In these programs, nurses play a fundamental role in educating, training, and monitoring users, which strengthens their ability to act promptly in emergencies related to substance use25.

Additionally, prevention interventions focused on strategies for access to supplies for safe use—such as needle exchange programs or the provision of sterile equipment—aim to reduce the transmission of infections like HIV and viral hepatitis, among other complications related to injectable substances. These interventions seek to build trust among users in these settings and strengthen links with other health services33,37.

Similarly, the reviewed literature highlights the importance of interventions related to accompaniment, counseling, and psychosocial support, which are essential for comprehensively addressing the needs of people who use drugs. These strategies promote adherence to treatment, facilitate access to mental health services, and help reduce the stigma associated with drug use—factors that, collectively, are associated with improvements in quality of life and continuity of health care26,27.

A comparison of the analyzed studies shows that harm reduction interventions can be implemented in various care settings—including hospitals, community-based settings, or specialized programs—sharing the goal of reducing the negative consequences of drug use without necessarily requiring abstinence. However, the scope and intensity of the interventions vary across studies, making it difficult to clearly establish which ones are most effective or offer the best cost-effectiveness for health systems.

These differences reflect the diversity of approaches within the harm reduction model and highlight the need to adapt interventions to the specific characteristics of the context, available resources, and the particularities of the population served7,38,39.

Among the main limitations of this study is the limited availability of scientific literature on nursing interventions for harm reduction in the primary health care setting, especially in Latin American contexts. This situation restricts the possibility of extrapolating the findings to health systems and sociocultural realities specific to the region. Additionally, it was found that many of the available studies analyze drug use in relation to various comorbidities, which can create methodological difficulties, given that there is not always a direct causal relationship between these conditions and substance use. This interrelationship can hinder the precise identification of nursing interventions specifically aimed at harm reduction, introducing potential biases in the interpretation of the evidence.

The review did not include a systematic assessment of the methodological quality of the selected studies, a factor that should be taken into account when interpreting the results. In addition, a significant proportion of the studies analyzed (approximately 83%) originated in the United States or other developed countries, suggesting the need for cultural, organizational, and structural adaptations for their implementation in Latin American health systems.

Finally, based on the findings identified, it is recommended to strengthen recognition of the role of nursing professionals in the comprehensive care of people who use drugs, promoting greater levels of professional autonomy in clinical decision-making based on scientific evidence. Similarly, it is essential that health policies incorporate strategies aimed at optimizing the use of available resources, prioritizing the prevention of adverse events and the reduction of complications associated with drug use. In this regard, it is necessary to promote new research that delves deeper into the effectiveness of nursing interventions for harm reduction, particularly in Latin American contexts, to generate contextualized evidence that informs the design of more relevant and effective care policies and practices.

Conclusions

Through a comprehensive analysis of the literature, various interventions carried out by nursing professionals were identified, with education, counseling, emotional support, and clinical treatment being the most prominent. However, specific harm reduction strategies, such as training and the distribution of naloxone for overdose prevention, were less frequently reported in the analyzed studies, highlighting a gap in current research. Nevertheless, these strategies highlight the comprehensive role of nursing, not only in the clinical management of addiction but also in risk prevention through educational and supportive interventions.

It was observed that educational and preventive interventions were the most frequent, particularly among adolescents in school settings, helping to prevent the progression from experimental use to abuse or drug dependence. Likewise, clinical interventions proved to be fundamental in improving treatment adherence and reducing overdose mortality rates. Meanwhile, risk mitigation strategies and emotional support promote users’ well-being and reduce harm associated with drug use. This highlights the role of nursing staff in disciplinary competencies that enable them to lead harm-reduction interventions, ensuring comprehensive care that addresses the biological, psychological, and social dimensions of the individual.

Most of the included studies were conducted in the United States, which limits the transferability of the results to other sociocultural and healthcare contexts. In this regard, it is recommended to promote research in local contexts evaluating harm reduction strategies and nursing-led care models, with the aim of generating contextualized evidence that contributes to strengthening public policies and care programs in the region.

References

1United Nations Office on Drugs and CrimeWorld Drug Report: Key Messages. n.d. [Internet] 2023 [cited 2024 sept 3]https://www.unodc.org/res/WDR-2023/Special_Points_WDR2023_web_DP.pdf

2Organización Mundial de la Salud (OMS)Drogas y sustancias psicoactivas Consulta: Septiembre 3; 2024https://www.paho.org/es/temas/abuso-sustancias

3Oficina de las Naciones Unidas contra la Droga y el Delito (UNODC)Estudio de consumo de sustancias psicoactivas en Bogotá D.C 2022 Consulta: Septiembre 3; 2024https://www.unodc.org/documents/colombia/2023/septiembre-9/ESTUDIO_DE_CONSUMO_DE_SUSTANCIAS_PSICOACTIVAS_BOGOTA_2022.pdf

4Quimbita Cangui DD Factores Psicosociales Asociados al Consumo de Sustancias En Un Centro de Rehabilitación [Tesis de grado licenciatura en Psicología] Ambato; Ecuador Universidad Tecnológica Indoamérica 2023 https://hdl.handle.net/20.500.14809/6028

5Castro-Calle SJ Orosco-Rosado DD Murillo-Zavala AM Carreño-Mera GM Conductas adictivas en adolescentes: prevalencia; factores de riego y complicaciones MQRInvestigar 2023 7 3 3545 3560 10.56048/MQR20225.7.3.2023.3545-3560

6Rodríguez M Solari S León L Ramírez J Pérez O Guarda E Complicaciones cardiovasculares por uso de cocaína Rev Chil Cardiol 2007 26 459 466 https://www.sscardio.org/wp-content/uploads/2008/rodriguez.pdf

7Chasillacta FB Núñez FR Rol del personal de enfermería en la atención primaria en salud Salud; Ciencia y Tecnología 2022 2 82 10.56294/saludcyt202282

8Programa de las Naciones Unidas para el DesarrolloObjetivo 3: Salud y Bienestar; Objetivos de Desarrollo Sostenible Consulta: Agosto 26; 2024https://www.undp.org/es/sustainable-development-goals/salud-bienestar

9Colledge-Frisby S Ottaviano S Webb P Grebely J Wheeler A Cunningham EB Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review Lancet Glob Health 2023 11 5 e673 683 10.1016/S2214-109X(23)00058-X

10Wiessing L Ferri M Běláčková V Carrieri P Friedman SR Folch C Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study Harm Reduct J 2017 14 19 10.1186/s12954-017-0141-6

11Magwood O Salvalaggio G Beder M Kendall C Kpade V Daghmach W The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities; managed alcohol programs; and pharmacological agents for opioid use disorder PloS One 2020 15 1 e0227298 10.1371/journal.pone.0227298

12Clua-García R La gestión de placeres y daños: Estudio etnográfico sobre el consumo de drogas en vía pública; viviendas y salas de consumo higiénico Salud Colect 2020 16 65 66 10.18294/sc.2020.2481

13Ondocsin J Ciccarone D Moran L Outram S Werb D Thomas L Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs Int J Environ Res Public Health 2023 20 11 5999 10.3390/ijerph20115999

14Romero Acosta DS Rol de Enfermería Frente a La Prevención; El Tratamiento y La Rehabilitación Del Consumo de SPA [Tesis de grado Enfermería] Bogotá; ColombiaUniversidad de Ciencias Aplicadas y Ambientales UDCA 2018 https://repository.udca.edu.co/entities/publication/66926bce-016c-41a5-b7d3-13bf5adf2ae6

15López Alabarce JA Hernández Sánchez D Molina Mula J Fernández Medina JM Castaño Fernández AI Sanz Álvarez E Percepción; conocimientos y actitudes de las enfermeras de urgencias y salud mental frente al alcoholismo y otras drogodependencias Metas Enferm 2014 17 2 22 31 https://www.enfermeria21.com/revistas/metas/articulo/80555/

16Martínez Esquivel D Cualidades del personal de enfermería en salud mental para las consejerías en adicción a drogas Enferm Actual de Costa Rica 2019 37 223 233 https://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-45682019000200223

17Organización Panamericana de la Salud (OPS)Atención Primaria de Salud Consulta: Septiembre 3; 2024https://www.paho.org/es/temas/atencion-primaria-salud

18Starfield B Atención Primaria: Equilibro Entre Necesidades de Salud; Servicios y Tecnología Masson: Nueva York; NY; Estados Unidos de AméricaOxford University Press 1998

19Levac D Colquhoun H O’Brien KK Scoping studies: advancing methodology Implement Sci 2010 5 69 10.1186/1748-5908-5-69

20Ouzzani M Hammady H Fedorowicz Z Elmagarmid A Rayyan — a web and mobile app for systematic reviews Systematic Reviews 2016 5 210 10.1186/s13643-016-0384-4

21Tricco AC Lillie E Zarin W O'Brien KK Colquhoun H Levac D PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation Ann Intern Med 2018 169 7 467 473 10.7326/M18-0850

22Sánchez-Rodríguez JM Acuña-Forero LM Sosa-Rodríguez YL Cárdenas-Martínez FJ Intervenciones de enfermería en Atención Primaria en Salud para la reducción de daños asociados al consumo de drogas: Scoping review Figshare 2025 10.6084/m9.figshare.29371472

23Ministerio de Salud - República de ColombiaResolución 8430 de 1993. Por la cual se establecen las normas científicas; técnicas y administrativas para la investigación en salud Consulta: Septiembre 3; 2024

24Gutierrez A Sher L Alcohol and drug use among adolescents: an educational overview Int J Adolesc Med Health 2015 27 2 207 12 10.1515/ijamh-2015-5013

25World Health OrganizationManagement of common health problems of drug users. Regional Office for South-East Asia [Internet] 2008 [cited 2008 April 8]https://iris.who.int/bitstreams/e97ba910-52a7-4527-8fd7-2c91fe405d22/download

26Pengpid S Peltzer K Van der Heever H Skaal L Screening and brief interventions for hazardous and harmful alcohol use among university students in South Africa: results from a randomized controlled trial Int J Environ Res Public Health 2013 10 5 2043 57 10.3390/ijerph10052043

27Patestos C Patterson K Fitzsimons V Substance abuse prevention: the role of the school nurse across the continuum of care NASN Sch Nurse 2014 29 6 310 4 10.1177/1942602x14542655

28Lintzeris N Monds LA Bravo M Read P Harrod ME Gilliver R Designing; implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives Drug Alcohol Rev 2020 39 1 55 65 10.1111/dar.13015

29Morales Loyola M Iniciativa educativa e-Salud con enfoque en reducción de riesgos y daños del consumo de sustancias psicoactivas en adolescentes escolarizados del Estado de México [Tesis de posgrado] Escuela de Salud Pública de México: Cuernavaca; Morelos2022

30Burr CK Storm DS Hoyt MJ Dutton L Berezny L Allread V Integrating health and prevention services in syringe access programs: a strategy to address unmet needs in a high-risk population Public Health Rep 2014 129 26 32 10.1177/00333549141291s105

31Cataldo JK The role of advanced practice psychiatric nurses in treating tobacco use and dependence Arch Psychiatr Nurs 2001 15 3 107 19 10.1053/apnu.2001.23749

32Sharma M Lamba W Cauderella A Guimond TH Bayoumi AM Harm reduction in hospitals Harm Reduct J 2017 14 10.1186/s12954-017-0163-0

33Perera R Stephan L Appa A Giuliano R Hoffman R Lum P Meeting people where they are: implementing hospital-based substance use harm reduction Harm Reduct J 2022 19 10.1186/s12954-022-00594-9

34Mullennix SC Iseler J Kwiatkowski GM McCann-Spry L Skinner J Kuhl N A Clinical Nurse Specialist-Led Emergency Department Naloxone Distribution Program Clin Nurse Spec CNS 2020 34 3 116 123 10.1097/NUR.0000000000000515

35Clua-García R Cuidados de Enfermería y Promoción de La Salud En Las Salas de Consumo Higiénico Cultura De Los Cuidados 2021 25 60 193 211 https://culturacuidados.ua.es/article/view/2021-n60-Cuidados-de-enfermer%C3%ADa-y-promoci%C3%B3n-de-la-salud-en-las

36Smith J Primary care: balancing health needs; services and technology Int J Integr Care 2001 1 e36 https://pmc.ncbi.nlm.nih.gov/articles/PMC1484414/

37Harm Reduction International¿Qué es Reducción de Daños? Consulta: Septiembre 3; 2024https://hri.global/what-is-harm-reduction/spanish/

38Ramos Calero E Enfermería Comunitaria Métodos y Técnicas 2a. ed La Enfermería Viva. Enfermería 21 Difusión Avances de Enfermería: Madrid 2002

39Sánchez Hervás E Tomás Gradolí V del Olmo Gurrea R Molina Bou N Morales Gallús E Terapia cognitivo-conductual breve en un grupo de dependientes a drogas Revista de la Asociación Española de Neuropsiquiatría 2002 81 21 29 https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-57352002000100003

Come citare questo studio

Acuña-Forero LM, Sosa-Rodríguez YL, Cárdenas-Martínez FJ, Sánchez-Rodríguez JM. (2026). Primary health care nursing interventions for people who use drugs: a scoping review.. Revista Cuidarte. DOI: 10.15649/cuidarte.5254

Consulta la pubblicazione originale ↗